TL;DRPMOS, formerly PCOS, is a hormonal disorder affecting approximately one in eight women but remains poorly understood. A new name and guidelines are intended to improve care for those affected.
TL;DRThe fastest-growing Ebola outbreak in history has claimed over 1,000 lives in eastern Congo. Fighting, distrust, and the absence of approved therapies are hindering the efforts of medical professionals to combat the virus.
TL;DRA video circulating on Facebook falsely claims to show electoral fraud against the AfD. Fact-checking by correctiv.org clarifies that the footage depicts the falsification of mail-in ballots.
TL;DRThe West Nile Virus is spreading across Europe and is considered established in Greece and Germany. Italy, Spain, Romania, and North Macedonia are also experiencing transmission of the virus.
TL;DRA study indicates that individuals undergoing GLP-1 therapy experience a minor, yet tangible, increase in the risk of hair loss. This risk is notably higher when compared to other diabetes medications.
TL;DRIn the Democratic Republic of Congo, more than 1,000 people have died from Ebola. There are currently no available medications or vaccines for the current virus variant.
TL;DRProgressive Democrats are achieving victories in US congressional primaries. This raises questions about their potential success in the November elections.
TL;DRA video circulating since 2018 shows a burning mobile mast in India, but it has no connection to the rollout of 5G mobile technology. At the time the video was recorded, 5G was not yet available in India.
TL;DRNicaraguan President Ortega has announced that the country will no longer hold elections in the future. This decision effectively suspends the previously scheduled presidential elections that were set to take place next year.
TL;DRA study presented at the International AIDS Conference indicates that HIV treatment rates for children have decreased following the withdrawal of the U.S. Agency for International Development (USAID). The U.S. government discontinued the agency during the second term of President Trump.